In IDHmut non-gliomas, residing in environments with low glutamate concentrations, this rescue pathway may start with the import of glutamine that is first converted to glutamate by mitochondrial glutaminase (GLS), followed by GLUD1/2-mediated further processing to α-KG. The gene discussed is GLUD1; the disease is central nervous system cancer.